- Home
- Equipment
- asia middle east
- follow up treatment
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Follow Up Treatment Equipment Supplied In Asia Middle East
5 equipment items found
Manufactured by:Victor Medical Instruments Co., Ltd based inChangzhou, CHINA
The single use anorectal ligation device is mainly composed of a protective cover, an inhalation tube, a ferrule, a firing ring, a firing rod, a reset button, a fixed handle, an inhalation switch, a negative pressure trachea connector, a trigger, etc.; the accessories include a peep sleeve and an anal plug. Use sterile products. The ferrule ferrule assembly is mainly composed of a protective ...
Manufactured by:Dornier MedTech GmbH based inWeßling, GERMANY
It uses an intelligent algorithm to enhance the image, neutralizing the negative optical effects caused by difficult scenarios such as obesity and bowel gases, By giving the urologist enhanced images, OptiVision allows for better diagnosis, better treatment, and better patient follow-up at no additional radiation ...
by:Pars Isotope Co based inTehran, IRAN
Lu-177-PSMA is a theranostic radiopharmaceutical designed for the treatment of metastatic prostate cancer. Employing the Peptide Receptor Radionuclide Therapy (PRRT) technique, it selectively targets and binds to prostate tumor cells, facilitating the destruction of malignant cells. This unique action stems from its characteristic as a gamma emitter, allowing not only for ...
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOTATE theranostic radiopharmaceutical kit is an innovative solution formulated as a single vial for the effective treatment of neuroendocrine tumors. It utilizes the Lu-177 radioisotope, enabling the radiopharmaceutical to selectively target neuroendocrine tumor cells, facilitating their complete destruction. This procedure not only assists in treatment but also enhances diagnostic ...
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOPSMA kit is an innovative theranostic radiopharmaceutical developed by Parsisotope Company, designed specifically for the treatment of metastatic prostate cancer. This kit is notable for being the first of its kind globally, and is used in conjunction with the Lu-177 radioisotope. It targets prostate-specific membrane antigen (PSMA), a membrane glycoprotein, the expression of which ...